Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection

References

• PrasadAGSchaudluRApteRSIntravitreal pharmacotherapy: applications in retinal diseaseCompr Ophthalmol Update20078525926918201513
   PubMedGoogle Scholar
• IrigoyenCZiahosseiniKMorphisGStapplerTHeimannHEndophthalmitis following intravitreal injectionsGraefes Arch Clin Exp Ophthalmol2012250449950522048244
   PubMed Web of Science ®Google Scholar
• BodaghiBKorobelnikJFCochereauIHajjarJGoebelFDumarcetNAFSSAPS (Association Francaise de Securite Sanitaire des Produits de Sante)Intravitreal injections: AFSSAPS guide to good practiceJ Fr Ophtalmol20123516971 French22226388
   PubMed Web of Science ®Google Scholar
• WaisbourdMGoldsteinMLoewensteinANational survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in IsraelIsr Med Assoc J201113314114621608333
   PubMed Web of Science ®Google Scholar
• SimunovicMPRushRBHunyorAPChangAAEndophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomesBr J Ophthalmol201296686286622446145
   PubMed Web of Science ®Google Scholar
• BhavsarARStockdaleCRFerrisFLBruckerAJBresslerNMGlassmanARDiabetic Retinopathy Clinical Research Network FTUpdate on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibioticsArch Ophthalmol2012130680981022801859
   PubMed Web of Science ®Google Scholar
• Angulo BoccoMCGlacet-BernardAZourdaniACoscasGSoubraneGIntravitreous injection: retrospective study on 2028 injections and their side effectsJ Fr Ophtalmol2008317693698 French18971854
   PubMed Web of Science ®Google Scholar
• CheungCSWongAWLuiAKertesPJDevenyiRGLamWCIncidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injectionsOphthalmology201211981609161422480743
   PubMed Web of Science ®Google Scholar
• MoshfeghiAARosenfeldPJFlynnHWJrEndophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral centerRetina201131466266821836400
   PubMed Web of Science ®Google Scholar
• JensenMKFiscellaRGMoshirfarMMooneyBThird- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 yearsJ Cataract Refract Surg20083491460146718721704
   PubMed Web of Science ®Google Scholar
• O’BrienTPArshinoffSAMahFSPerspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacinJ Cataract Refract Surg200733101790180017889778
   PubMed Web of Science ®Google Scholar
• WejdeGMontanPLundströmMSteneviUThorburnWEndophthalmitis following cataract surgery in Sweden: national prospective survey 1999–2001Acta Ophthalmol Scand200583171015715550
   PubMedGoogle Scholar
• SealDVBarryPGettinbyGESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter studyJ Cataract Refract Surg200632339640616631046
   PubMed Web of Science ®Google Scholar
• GaratMMoserCLMartín-BaraneraMAlonso-TarrésCAlvarez-RubioLProphylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year studyJ Cataract Refract Surg200935463764219304083
   PubMed Web of Science ®Google Scholar
• RomeroPMéndezISalvatMFernándezJAlmenaMIntracameral cefazolin as prophylaxis against endophthalmitis in cataract surgeryJ Cataract Refract Surg200632343844116631053
   PubMed Web of Science ®Google Scholar
• ScottIUFlynnHWJrReducing the risk of endophthalmitis following intravitreal injectionsRetina2007271101217218909
   PubMed Web of Science ®Google Scholar
• BhavsarARGoogeJMJrStockdaleCRRisk of endophthalmitis after intravitreal injection when topical antibiotics are not requiredArch Ophthalmol2009127121581158320008710
   PubMedGoogle Scholar
• JagerRDAielloLPPatelSCCunninghamETJrRisks of intravitreous injection: a comprehensive reviewRetina200424567669815492621
   PubMed Web of Science ®Google Scholar
• Endophthalmitis Vitrectomy Study GroupResults of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitisArch Ophthalmol199511312147914967487614
   PubMedGoogle Scholar
• BarryPGardnerSSealDClinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgeryJ Cataract Refract Surg20093591523153119683148
   PubMed Web of Science ®Google Scholar
• BaqueroFMartínez-BeltránJCantónRCriteria of the MENSURA group for the definition of the critical points of sensitivity to antibioticsEnferm Infecc Microbiol Clin19981628592 Spanish9586367
   PubMedGoogle Scholar
• National Committee for Clinical Laboratory StandardsPerformance Standards for Antimicrobial Disk Susceptibility Tests: Approved StandardNCCLS document M2-A77th edWayne, PANational Committee for Clinical Laboratory Standards2002
   Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
   PubMed Web of Science ®Google Scholar
• BhavsarARIpMSGlassmanARDRCRnet and the SCORE Study GroupsThe risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trialsAm J Ophthalmol2007144345445617765429
   PubMed Web of Science ®Google Scholar
• Vitravene Study GroupSafety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDSAm J Ophthalmol2002133448449811931782
   PubMed Web of Science ®Google Scholar
• McCannelCAMeta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategiesRetina201131465466121330939
   PubMed Web of Science ®Google Scholar
• BhattSSStepienKEJoshiKProphylactic antibiotic use after intravitreal injection: effect on endophthalmitis rateRetina201131102032203621659941
   PubMed Web of Science ®Google Scholar
• Royal College of OphthalmologistsGuidelines for Intravitreal Injections ProcedureLondon, UKRoyal College of Ophthalmologists2009 Available from: http://www.rcophth.ac.ukAccessed August 28, 2012
   Google Scholar
• Sociedad Espanola de Retina y VítreoManejo de las inyecciones intravítreasManagement of intravitreal injectionsGuías de Práctica Clínica de la SERV2009 Available from: http://www.serv.esAccessed August 28, 2012 Spanish
   Google Scholar
• Agence Français de Sécurité Sanitaire des Produits de SantéBonnes pratiques d’injection intra-vitréennGood practice for intravitreal injection2011 Available from: http://www.ansm.frAccessed August 28, 2012 French
   Google Scholar
• RetsemaJGirardASchelklyWSpectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organismsAntimicrob Agents Chemother19873112193919472449865
   PubMed Web of Science ®Google Scholar
• PetersDHFriedelHAMcTavishDAzithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacyDrugs19924457507991280567
   PubMed Web of Science ®Google Scholar
• ChiambarettaFGarraffoRElenaPPTear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eye drops (T1225) in healthy volunteersEur J Ophthalmol2008181132018203079
   PubMed Web of Science ®Google Scholar
• CochereauIMeddeb-OuertaniAKhairallahM3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and childrenBr J Ophthalmol200791446546917050578
   PubMed Web of Science ®Google Scholar